Airway Endoscopes Market Size, Share, Growth, and Industry Analysis, By Type (Flexible Endoscope, Rigid Endoscope), By Application (Humanity, Animal), Regional Insights and Forecast to 2035

Airway Endoscopes Market Overview

The global Airway Endoscopes Market size estimated at USD 3202.95 million in 2026 and is projected to reach USD 3686.16 million by 2035, growing at a CAGR of 1.58% from 2026 to 2035.

The Airway Endoscopes Market is witnessing strong expansion due to the increasing prevalence of respiratory disorders, rising demand for minimally invasive diagnostic procedures, and growing adoption of advanced visualization technologies across hospitals and ambulatory surgical centers. More than 545 million people globally are affected by chronic respiratory diseases, creating sustained demand for bronchoscopy and airway visualization systems. Over 18 million bronchoscopic procedures are performed annually worldwide, with flexible airway endoscopes accounting for nearly 72% of total procedural usage. The Airway Endoscopes Market Report highlights rising integration of HD imaging, disposable endoscopes, and AI-assisted navigation systems. 

The United States dominates the Airway Endoscopes Market Share due to rising pulmonary disease incidence and high procedural volumes across healthcare facilities. More than 37 million Americans suffer from chronic lung diseases, while over 236,000 new lung cancer cases are diagnosed annually. Around 500,000 bronchoscopy procedures are conducted every year in the U.S., with tertiary hospitals accounting for nearly 64% of total airway endoscope utilization. Disposable airway endoscope adoption increased by over 41% in critical care units following infection-control protocols. Nearly 78% of pulmonology centers in the country use HD visualization airway systems.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: Over 64% of respiratory diagnostics now involve minimally invasive airway procedures, while lung cancer screening programs increased by 37%, and ICU airway monitoring demand rose by 43%, significantly supporting Airway Endoscopes Market Growth across hospitals and pulmonary specialty centers.
• Major Market Restraint: Nearly 46% of small healthcare facilities report procurement limitations due to high device maintenance costs, while 39% of clinics face sterilization compliance burdens and 31% experience shortages of trained bronchoscopy specialists affecting procedural efficiency.
• Emerging Trends: Disposable airway endoscope adoption expanded by 41%, AI-assisted bronchoscopy integration increased by 29%, and robotic navigation system installations grew by 32%, while portable wireless visualization systems witnessed 35% higher deployment in emergency and ICU applications.
• Regional Leadership: North America contributes approximately 39% of total procedural volume, Europe accounts for nearly 28%, Asia-Pacific exceeds 24%, while advanced pulmonary diagnostic infrastructure penetration in the United States surpasses 78% across tertiary healthcare institutions.
• Competitive Landscape: The top five manufacturers collectively account for nearly 57% of product installations, while approximately 48% of companies are investing in disposable technologies and 36% are expanding AI-based airway visualization product portfolios for hospital procurement contracts.
• Market Segmentation: Flexible airway endoscopes represent nearly 72% of demand, rigid airway endoscopes account for 28%, hospitals contribute 68% of total utilization, ambulatory surgical centers represent 19%, and pulmonary specialty clinics account for approximately 13% of procedures.
• Recent Development: More than 33% of new product launches feature single-use designs, 27% include AI-enhanced imaging capabilities, and 31% support robotic-assisted bronchoscopy compatibility, while cloud-based procedural data integration increased by approximately 24% across healthcare systems.

Airway Endoscopes Market Latest Trends

The Airway Endoscopes Market Trends indicate increasing demand for disposable and portable bronchoscopy systems due to growing infection-control concerns in hospitals and intensive care units. Disposable airway endoscope adoption expanded by nearly 41% globally, especially in emergency departments and critical care settings. More than 52% of hospitals are prioritizing single-use endoscopy systems to reduce cross-contamination risks and sterilization turnaround times. HD imaging and 4K visualization technologies are also transforming pulmonary diagnostics, with approximately 61% of newly installed systems equipped with advanced imaging capabilities. 

The Airway Endoscopes Market Outlook also reflects rapid technological advancements in robotic bronchoscopy and navigation-assisted airway diagnostics. Robotic-assisted bronchoscopy installations increased by approximately 32% across large healthcare networks, improving access to peripheral lung lesions and enhancing biopsy precision. Around 48% of pulmonary specialists are incorporating navigational bronchoscopy technologies into routine diagnostic pathways. Demand for wireless connectivity and cloud-based procedural data integration increased by nearly 24%, enabling remote consultation and improved clinical workflow management.

Airway Endoscopes Market Dynamics

DRIVER

"Increasing prevalence of respiratory diseases and lung cancer screening programs"

The growing burden of respiratory diseases is a major factor accelerating Airway Endoscopes Market Growth. More than 545 million individuals globally suffer from chronic respiratory disorders, while lung cancer remains among the leading causes of cancer-related mortality worldwide. Over 2.4 million new lung cancer cases are diagnosed annually, significantly increasing the demand for bronchoscopy and airway visualization procedures. Around 64% of pulmonary diagnostics now involve minimally invasive airway endoscopy technologies due to improved patient safety and reduced hospitalization duration. 

RESTRAINTS

"High equipment costs and sterilization compliance challenges"

The Airway Endoscopes Market Analysis identifies high capital investment and maintenance requirements as significant barriers for healthcare providers. Approximately 46% of smaller healthcare facilities face budgetary limitations affecting procurement of advanced bronchoscopy systems. Sterilization and infection-control compliance costs increased by nearly 34%, creating operational burdens for hospitals using reusable airway endoscopes. Nearly 39% of outpatient clinics reported delays in procedural scheduling due to reprocessing requirements and equipment turnaround times. 

OPPORTUNITY

"Expansion of robotic bronchoscopy and disposable airway technologies"

The rapid development of robotic-assisted bronchoscopy and disposable airway endoscopes is creating strong Airway Endoscopes Market Opportunities. Robotic bronchoscopy installations increased by over 32% across tertiary healthcare centers, improving precision in peripheral lung lesion diagnosis. Disposable airway endoscope demand rose by approximately 41%, particularly in emergency departments and ICUs aiming to reduce infection risks. Nearly 48% of medical device manufacturers are investing in AI-integrated bronchoscopy systems to improve lesion detection and procedural navigation. 

CHALLENGE

"Limited skilled workforce and procedural complexity"

The shortage of trained bronchoscopy professionals and procedural complexities remain key challenges within the Airway Endoscopes Market Forecast period. Approximately 33% of healthcare facilities report insufficient access to trained pulmonary endoscopy specialists, especially in emerging healthcare regions. Advanced robotic bronchoscopy systems require extensive physician training, with nearly 29% of hospitals indicating delays in adoption due to learning curve concerns. Complication risks associated with airway procedures affect approximately 12% of complex pulmonary interventions, increasing procedural caution among healthcare providers. 

Airway Endoscopes Market Segmentation

The Airway Endoscopes Market segmentation is categorized by type and application, reflecting diverse clinical and veterinary respiratory diagnostic requirements. By type, flexible endoscopes account for nearly 72% of global utilization due to superior maneuverability and increasing minimally invasive procedures, while rigid endoscopes contribute approximately 28% owing to their effectiveness in complex airway surgeries. By application, humanity-based procedures dominate with over 88% share because of growing pulmonary disease prevalence and bronchoscopy volumes. 

Download Free Sample to learn more about this report.

BY TYPE

Flexible Endoscope: Flexible airway endoscopes dominate the Airway Endoscopes Market Share with approximately 72% of total global product utilization due to their widespread adoption in minimally invasive pulmonary procedures and intensive care applications. These devices are increasingly preferred across hospitals and pulmonary specialty clinics because they offer superior maneuverability within narrow and complex airway structures. More than 18 million bronchoscopy procedures are performed globally every year, and nearly three-fourths involve flexible airway endoscopes. Healthcare institutions are rapidly upgrading toward HD and 4K flexible imaging systems, with approxim

Rigid Endoscope: Rigid airway endoscopes account for nearly 28% of the Airway Endoscopes Market Size and remain essential for complex airway surgeries, therapeutic bronchoscopy procedures, and foreign body removal interventions. These devices are widely utilized in advanced pulmonary care settings where stable airway access and larger working channels are required for interventional procedures. Approximately 39% of thoracic surgical centers globally continue to rely on rigid airway endoscopy systems for complex tracheal obstruction management and emergency airway stabilization procedures. Rigid airway endoscopes are commonly used in combination with laser therapy, airway stenting, and tumor debulking procedures, particularly among patients with severe airway narrowing and malignant respiratory conditions.

BY APPLICATION

Humanity: Humanity applications dominate the Airway Endoscopes Market Outlook with approximately 88% share of global demand due to the increasing prevalence of chronic respiratory disorders, lung cancer, airway infections, and critical care interventions. More than 545 million individuals worldwide suffer from chronic respiratory diseases, while over 2.4 million new lung cancer cases are diagnosed annually, creating substantial demand for bronchoscopy and airway visualization technologies. Hospitals perform nearly 500,000 bronchoscopy procedures annually in the United States alone, while tertiary pulmonary centers across Europe and Asia continue expanding advanced respiratory diagnostic capabilities. Around 64% of respiratory diagnostics now utilize minimally invasive airway endoscopy procedures due to shorter recovery periods and improved patient safety outcomes. Airway endoscopes are widely utilized in intensive care units, pulmonary medicine departments, oncology centers, and emergency medicine facilities for diagnostic and therapeutic procedures. Approximately 43% of ICU airway monitoring procedures now involve flexible airway endoscopy systems, especially for ventilated patients and severe respiratory distress cases.

Animal: Animal applications represent nearly 12% of the Airway Endoscopes Market Share and are experiencing increasing adoption due to rising veterinary healthcare spending, growing pet ownership, and expanding awareness regarding respiratory diseases in companion and livestock animals. Veterinary hospitals and specialty animal clinics are increasingly utilizing airway endoscopy technologies for diagnosing respiratory infections, airway obstructions, chronic coughing disorders, and pulmonary abnormalities in dogs, cats, horses, and livestock animals. Companion animal ownership increased by approximately 34% globally, significantly contributing to veterinary respiratory diagnostic procedure volumes. More than 29% of advanced veterinary clinics now maintain dedicated bronchoscopy equipment for respiratory examination and minimally invasive airway interventions. Equine respiratory diagnostics account for a substantial portion of veterinary airway endoscopy procedures because racehorses and performance animals frequently experience airway-related complications.

Airway Endoscopes Market Regional Outlook

The Airway Endoscopes Market Insights reveal strong regional variation driven by healthcare infrastructure, respiratory disease prevalence, technological adoption, and procedural volumes. North America leads the global market with approximately 39% share due to advanced pulmonary care systems, high bronchoscopy procedure rates, and strong adoption of AI-assisted and disposable airway endoscopes. Europe contributes nearly 28% of total market share, supported by increasing lung cancer screening programs and widespread hospital modernization initiatives. Asia-Pacific accounts for approximately 24% share and is witnessing rapid growth due to rising respiratory disorders, urban pollution exposure, and expanding healthcare investments. 

Download Free Sample to learn more about this report.

NORTH AMERICA

North America dominates the Airway Endoscopes Market with approximately 39% share of global demand, supported by advanced healthcare infrastructure, rising respiratory disease prevalence, and strong adoption of innovative bronchoscopy technologies. The United States contributes the largest portion of regional procedural volume, with more than 500,000 bronchoscopy procedures performed annually across hospitals, outpatient surgical centers, and pulmonary specialty clinics. Nearly 37 million Americans suffer from chronic respiratory disorders, including chronic obstructive pulmonary disease, asthma, and pulmonary fibrosis, significantly increasing demand for airway diagnostic procedures. More than 236,000 new lung cancer cases are diagnosed annually in the region, strengthening the need for advanced airway visualization and biopsy technologies. Hospitals across North America are rapidly transitioning toward minimally invasive pulmonary diagnostics, with approximately 64% of respiratory examinations involving flexible airway endoscopy systems. Disposable bronchoscopy technologies witnessed nearly 41% higher adoption in intensive care units and emergency departments due to increasing infection-control protocols and reduced sterilization requirements. 

EUROPE

Europe accounts for approximately 28% of the global Airway Endoscopes Market Share, supported by advanced healthcare infrastructure, rising respiratory disease prevalence, and increasing adoption of minimally invasive pulmonary diagnostic technologies. More than 65 million individuals across Europe suffer from chronic respiratory disorders, including asthma, chronic obstructive pulmonary disease, and lung cancer-related complications. Over 1.1 million bronchoscopy procedures are performed annually throughout the region, with Germany, the United Kingdom, France, and Italy representing the largest contributors to procedural volume. Nearly 69% of tertiary healthcare facilities in Europe use HD airway visualization systems for advanced pulmonary diagnostics and therapeutic bronchoscopy procedures. Germany remains the largest contributor to the regional market due to strong pulmonary care infrastructure and extensive healthcare investments. The United Kingdom continues expanding advanced bronchoscopy utilization through national respiratory disease management programs. Southern and Eastern European countries are also witnessing increasing demand for airway endoscopy technologies as hospital modernization projects and pulmonary diagnostic capacities continue expanding. 

GERMANY Airway Endoscopes Market

Germany represents one of the largest contributors to the Europe Airway Endoscopes Market, accounting for nearly 24% of the regional market share due to its advanced healthcare infrastructure, high procedural volumes, and extensive adoption of minimally invasive pulmonary diagnostic technologies. More than 8 million individuals in Germany suffer from chronic respiratory diseases, including chronic obstructive pulmonary disease, asthma, and pulmonary fibrosis. Lung cancer remains among the leading oncological concerns in the country, with over 57,000 new cases diagnosed annually, significantly increasing demand for bronchoscopy procedures and airway visualization systems. The country’s strong focus on medical innovation and physician training further strengthens the Germany Airway Endoscopes Market Outlook. Academic medical centers reported approximately 26% growth in simulation-based bronchoscopy training programs for pulmonologists and thoracic surgeons. Government-supported respiratory disease management initiatives and hospital modernization projects are increasing procurement of advanced bronchoscopy systems across public healthcare institutions. 

UNITED KINGDOM Airway Endoscopes Market

The United Kingdom Airway Endoscopes Market accounts for approximately 18% of the Europe regional share due to increasing respiratory disease prevalence, rising bronchoscopy procedure volumes, and continuous expansion of pulmonary diagnostic infrastructure. More than 7 million individuals in the United Kingdom are affected by chronic respiratory diseases, including asthma and chronic obstructive pulmonary disease. Lung cancer remains one of the leading causes of cancer-related mortality, with over 48,000 new cases diagnosed annually. These healthcare trends continue driving demand for minimally invasive airway diagnostic technologies and advanced bronchoscopy systems. Government-supported respiratory disease screening initiatives are contributing significantly to the United Kingdom Airway Endoscopes Market Growth. Lung cancer screening programs expanded by approximately 33%, increasing procedural demand for bronchoscopy-guided biopsy and airway visualization procedures. Academic hospitals and pulmonary research institutions reported around 24% growth in bronchoscopy simulation-based physician education programs to improve specialist training and procedural expertise. 

ASIA-PACIFIC

Asia-Pacific accounts for approximately 24% of the global Airway Endoscopes Market Share and represents one of the fastest-expanding regional healthcare sectors due to increasing respiratory disease prevalence, rising healthcare investments, and rapidly improving hospital infrastructure. More than 220 million individuals across Asia-Pacific suffer from chronic respiratory disorders, including asthma, chronic obstructive pulmonary disease, tuberculosis-related complications, and lung cancer. Urban pollution exposure, smoking prevalence, and industrial emissions continue contributing to growing pulmonary disease burdens throughout China, Japan, India, South Korea, and Southeast Asian countries. Over 3.5 million bronchoscopy procedures are performed annually across Asia-Pacific healthcare facilities, with procedural volumes increasing significantly in tertiary hospitals and pulmonary specialty centers. Government healthcare initiatives are significantly strengthening the Asia-Pacific Airway Endoscopes Market Outlook. Lung cancer screening and tuberculosis management programs expanded by approximately 35% across several countries, increasing demand for airway biopsy and visualization procedures. 

JAPAN Airway Endoscopes Market

Japan accounts for approximately 21% of the Asia-Pacific Airway Endoscopes Market Share due to its technologically advanced healthcare system, aging population, and strong adoption of minimally invasive pulmonary diagnostic procedures. More than 9 million individuals in Japan suffer from chronic respiratory conditions, including chronic obstructive pulmonary disease, asthma, and interstitial lung diseases. Lung cancer remains among the most prevalent cancers in the country, with over 125,000 new cases diagnosed annually, creating substantial demand for bronchoscopy procedures and airway visualization technologies. The aging demographic structure in Japan continues driving procedural demand for airway endoscopy technologies. More than 29% of the population is aged above 65 years, contributing significantly to respiratory disease incidence and pulmonary diagnostic requirements. Government-supported lung cancer screening initiatives expanded by approximately 32%, increasing bronchoscopy-guided biopsy procedures throughout the country. 

CHINA Airway Endoscopes Market

China represents the largest contributor to the Asia-Pacific Airway Endoscopes Market, accounting for approximately 38% of the regional market share due to rising respiratory disease prevalence, rapid hospital infrastructure expansion, and increasing adoption of advanced pulmonary diagnostic technologies. More than 100 million individuals in China suffer from chronic respiratory disorders, including chronic obstructive pulmonary disease, asthma, and smoking-related pulmonary complications. Lung cancer remains the most commonly diagnosed cancer in the country, with over 820,000 new cases reported annually, significantly increasing demand for bronchoscopy and airway visualization systems. More than 1.2 million bronchoscopy procedures are performed annually across Chinese healthcare institutions, with large urban hospitals accounting for nearly 71% of procedural activity. Approximately 61% of tertiary pulmonary centers utilize HD bronchoscopy systems for advanced respiratory diagnostics and minimally invasive airway interventions. 

MIDDLE EAST & AFRICA

The Middle East & Africa Airway Endoscopes Market accounts for approximately 3% of global market share and is steadily expanding due to increasing healthcare investments, growing respiratory disease prevalence, and improving access to advanced pulmonary diagnostic technologies. More than 35 million individuals across the region suffer from respiratory disorders associated with smoking, air pollution exposure, occupational hazards, and infectious pulmonary diseases. Increasing urbanization and industrial development continue contributing to rising incidences of chronic obstructive pulmonary disease, asthma, and lung infections. Approximately 420,000 bronchoscopy procedures are performed annually across healthcare facilities in the Middle East & Africa region, with procedural volumes steadily increasing in tertiary hospitals and specialized respiratory treatment centers. Saudi Arabia and the United Arab Emirates remain the leading contributors to the regional market due to substantial healthcare modernization initiatives and increasing investments in advanced medical technologies. 

List of Key Airway Endoscopes Market Companies

• Boston Scientific
• Olympus
• Karl Storz
• Stryker
• Hoya
• Fujifilm
• Richard Wolf
• Medtronic
• Conmed
• Smith & Nephew
• Arthrex
• B. Braun Melsungen
• XION Medical

Top Two Companies with Highest Share

• Olympus: Holds approximately 29% share in the Airway Endoscopes Market due to strong bronchoscopy product penetration, advanced HD imaging systems, and widespread hospital adoption across North America, Europe, and Asia-Pacific pulmonary care facilities.
• Karl Storz: Accounts for nearly 18% market share supported by extensive rigid and flexible airway endoscopy portfolios, growing interventional pulmonology demand, and increasing adoption across thoracic surgery and respiratory diagnostic centers globally.

Investment Analysis and Opportunities

The Airway Endoscopes Market is attracting substantial investments due to rising respiratory disease prevalence, increasing demand for minimally invasive diagnostics, and expanding pulmonary healthcare infrastructure worldwide. Approximately 48% of medical device manufacturers are increasing investments in disposable airway endoscopy technologies to address infection-control requirements and reduce sterilization complexities in hospitals. Around 42% of healthcare institutions globally are expanding pulmonary diagnostic departments, creating significant procurement opportunities for advanced bronchoscopy systems and airway visualization technologies. Investment in AI-assisted bronchoscopy software increased by nearly 31%, particularly in North America, Europe, and Asia-Pacific, where hospitals are prioritizing improved lesion detection accuracy and procedural efficiency.

Robotic-assisted bronchoscopy technologies are emerging as a major investment opportunity within the Airway Endoscopes Market Outlook. Approximately 29% of tertiary pulmonary care centers are allocating capital toward robotic navigation systems for advanced airway interventions and peripheral lung lesion biopsies. Portable airway endoscopy systems recorded approximately 35% higher investment activity due to increasing demand from ambulatory surgical centers, emergency medicine facilities, and rural healthcare providers. Government-backed respiratory disease screening programs expanded by nearly 37%, increasing demand for flexible airway endoscopes and HD visualization systems. Academic hospitals and research institutions also increased investments in bronchoscopy simulation laboratories by approximately 27% to improve physician training and procedural expertise. Asia-Pacific healthcare infrastructure projects contributed nearly 38% growth in respiratory care equipment procurement, strengthening long-term opportunities for airway endoscope manufacturers and technology developers.

New Products Development

The Airway Endoscopes Market is witnessing rapid product innovation focused on improving imaging quality, infection control, portability, and procedural precision. Approximately 33% of newly introduced airway endoscopy systems now feature disposable configurations designed to reduce cross-contamination risks and eliminate sterilization delays in hospitals and intensive care units. HD and 4K imaging technologies were integrated into nearly 61% of newly launched bronchoscopy platforms, significantly improving airway visualization and lesion identification capabilities. AI-assisted bronchoscopy software integration increased by approximately 28%, enhancing real-time lesion detection and navigation support during complex pulmonary procedures.

Manufacturers are also focusing on robotic-assisted bronchoscopy and wireless connectivity technologies to improve procedural workflow and diagnostic outcomes. Around 31% of newly developed airway endoscopy systems support robotic navigation compatibility for minimally invasive pulmonary interventions. Portable airway visualization systems recorded approximately 34% growth in new product introductions due to increasing demand from ambulatory care centers and emergency healthcare facilities. Cloud-enabled bronchoscopy data integration features expanded by nearly 24%, enabling remote consultation and streamlined clinical documentation. Pediatric airway endoscope innovations increased by approximately 21%, addressing growing demand for specialized respiratory diagnostics in neonatal and pediatric healthcare settings.

Five Recent Developments

• Olympus expanded its disposable bronchoscopy portfolio in 2024 with advanced HD imaging integration, improving airway visualization efficiency by approximately 26%. The company reported nearly 39% higher adoption of single-use airway endoscopes across intensive care units and emergency respiratory treatment centers globally.

• Karl Storz introduced upgraded robotic-compatible bronchoscopy systems in 2024 featuring enhanced navigation accuracy and integrated AI-assisted lesion detection capabilities. Hospitals using the new systems reported approximately 24% improvement in peripheral lung lesion accessibility during advanced pulmonary diagnostic procedures.

• Fujifilm launched advanced portable airway endoscopy systems in 2024 targeting ambulatory surgical centers and mobile healthcare applications. The company observed approximately 31% growth in demand for lightweight bronchoscopy devices equipped with wireless image transmission and HD visualization capabilities.

• Boston Scientific increased investment in AI-enabled bronchoscopy technologies in 2024, focusing on improving procedural workflow and pulmonary lesion detection efficiency. Clinical adoption of the upgraded systems increased by nearly 27% across thoracic oncology and respiratory diagnostic centers.

• Medtronic expanded its interventional pulmonology product line in 2024 with integrated navigation-assisted airway endoscopy solutions for minimally invasive respiratory procedures. Healthcare facilities utilizing these technologies reported approximately 22% improvement in biopsy precision and procedural navigation efficiency.

Report Coverage Of Airway Endoscopes Market

The Airway Endoscopes Market Report provides comprehensive analysis of market segmentation, competitive landscape, technological advancements, regional outlook, investment trends, and emerging opportunities across the global pulmonary diagnostics industry. The report evaluates flexible and rigid airway endoscope utilization trends, with flexible systems accounting for nearly 72% of total product demand globally. Hospitals contribute approximately 68% of total airway endoscope utilization due to increasing bronchoscopy procedure volumes and expanding respiratory disease management infrastructure. The study also examines application-based demand patterns across humanity and veterinary healthcare sectors, where humanity applications represent nearly 88% of procedural activity worldwide.

The report further analyzes regional market performance across North America, Europe, Asia-Pacific, and Middle East & Africa, highlighting North America’s approximately 39% global market share and Asia-Pacific’s rapidly expanding pulmonary care infrastructure. Around 41% growth in disposable airway endoscope adoption and approximately 32% increase in robotic bronchoscopy installations are thoroughly assessed within the study. The report also evaluates AI-assisted bronchoscopy integration trends, HD visualization technology penetration, cloud-based respiratory diagnostic management systems, and portable airway endoscopy innovations. Competitive profiling includes analysis of major manufacturers, product development strategies, healthcare investment patterns, and hospital procurement activities shaping the Airway Endoscopes Market Forecast and long-term industry expansion.